We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
(+4.5%)
Cap. Flow
+$77.2M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$53.4M |
| 2 |
Occidental Petroleum
OXY
|
+$38M |
| 3 |
Capital One
COF
|
+$36.7M |
| 4 |
Elevance Health
ELV
|
+$27.1M |
| 5 |
Kroger
KR
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$43.2M |
| 2 |
Microsoft
MSFT
|
+$36.6M |
| 3 |
Qualcomm
QCOM
|
+$34.8M |
| 4 |
Mastercard
MA
|
+$33.6M |
| 5 |
Merck
MRK
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Financials | 13.21% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Covenant Logistics
CVLG
$1.04B
| $283K | ﹤0.01% |
32,306
| – | – |
|
902
Energy Recovery
ERII
$420M
| $283K | ﹤0.01% |
34,558
-11,139
| -24% | -$89.3K |
|
|
PROS
903
DELISTED
ProSight Global, Inc.
PROS
| $283K | ﹤0.01% |
24,940
-20,926
| -46% | -$193K |
|
|
CMA
904
DELISTED
Comerica
CMA
| $276K | ﹤0.01% |
+7,220
| New | +$278K |
|
|
TXNM
905
TXNM Energy Inc
TXNM
$6.39B
| $274K | ﹤0.01% |
6,638
-6,097
| -48% | -$254K |
|
906
Selective Insurance
SIGI
$5.76B
| $272K | ﹤0.01% |
5,292
-31,816
| -86% | -$1.75M |
|
|
UCB
907
United Community Banks
UCB
$4.26B
| $270K | ﹤0.01% |
15,923
-1,620
| -9% | -$29.2K |
|
|
STXB
908
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $270K | ﹤0.01% |
24,166
+1,950
| +9% | +$23K |
|
909
SunCoke Energy
SXC
$794M
| $267K | ﹤0.01% |
+77,931
| New | +$254K |
|
|
ETNB
910
DELISTED
89bio
ETNB
| $266K | ﹤0.01% |
+10,369
| New | +$329K |
|
911
Auburn National Bancorp
AUBN
$91.8M
| $259K | ﹤0.01% |
+7,145
| New | +$315K |
|
912
First Merchants
FRME
$2.69B
| $259K | ﹤0.01% |
11,185
-3,437
| -24% | -$85.8K |
|
913
Bassett Furniture
BSET
$169M
| $258K | ﹤0.01% |
+18,828
| New | +$197K |
|
914
Hormel Foods
HRL
$14.2B
| $258K | ﹤0.01% |
5,283
+461
| +10% | +$23.1K |
|
|
IVAC
915
DELISTED
Intevac Inc
IVAC
| $257K | ﹤0.01% |
46,624
-11,702
| -20% | -$67.5K |
|
|
QTNT
916
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $256K | ﹤0.01% |
+1,246
| New | +$323K |
|
|
ACGN
917
DELISTED
Aceragen Inc
ACGN
| $255K | ﹤0.01% |
7,013
+830
| +13% | +$29.5K |
|
918
Medtronic
MDT
$112B
| $254K | ﹤0.01% |
2,448
-3,145
| -56% | -$316K |
|
919
Bank of N.T. Butterfield & Son
NTB
$2.41B
| $254K | ﹤0.01% |
11,399
-28,594
| -71% | -$716K |
|
920
Stoneridge
SRI
$200M
| $252K | ﹤0.01% |
+13,700
| New | +$279K |
|
921
Dianthus Therapeutics
DNTH
$5.69B
| $248K | ﹤0.01% |
2,278
-180
| -7% | -$21.3K |
|
922
Esquire Financial Holdings
ESQ
$1.14B
| $245K | ﹤0.01% |
16,327
-3,524
| -18% | -$56.3K |
|
|
HALL
923
DELISTED
Hallmark Financial Services, Inc.
HALL
| $245K | ﹤0.01% |
9,335
-2,430
| -21% | -$75.8K |
|
924
CEVA Inc
CEVA
$831M
| $244K | ﹤0.01% |
6,187
-46,316
| -88% | -$1.84M |
|
|
BIOR
925
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $243K | ﹤0.01% |
+108
| New | +$244K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2020 Portfolio in Review
As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
- Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
- Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
- Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
- Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.